Follow
Oncology Molecular Diagnostic
Clinical Oncology evaluations can include various molecular tests and the results can influence patient care. One example of an Oncology Molecular Diagnostic is mutation analysis for genes known to be confer a high risk of cancer such as BRCA1/2. Healthy patients found to carry this mutation benefit from increased screening and surveillance due to their increased risk of several cancers.
-
FEB 22, 2024Clinical & Molecular DX
A new tool has been developed to detect skin cancer; it utilizes a biosensor that can identify small changes in the char ...Written By: Carmen LeitchJAN 04, 2024Clinical & Molecular DX
After leukemia, tumors of the central nervous system (CNS) are second most common cancer in children, and the primary ca ...Written By: Carmen LeitchDEC 13, 2023Genetics & Genomics
Human immunity is an incredibly complex system that have to be very carefully regulated by the body. We need our immune ...Written By: Carmen LeitchNOV 10, 2023Clinical & Molecular DX
Globally, bladder cancer is the ninth most commonly diagnosed cancer and is the 13th leading cause of cancer-related dea ...Written By: Carmen LeitchOCT 24, 2023Technology
A team of researchers at the University Medical Center Utrecht and the Princess Máxima Center for pediatric oncol ...Written By: Ryan VingumOCT 11, 2023Clinical & Molecular DX
Tumors in the central nervous system are particularly deadly. During surgery to remove a brain tumor, surgeons usually h ...Written By: Carmen LeitchSEP 29, 2023Clinical & Molecular DX
The brain is a crucial, sensitive organ that is well-protected by the skull and blood brain barrier, which prevents many ...Written By: Carmen LeitchAUG 17, 2023Technology
A recent study published in Nature Machine Intelligence examines a novel deep-learning method known as BigMHC, which can ...Written By: Laurence Tognetti, MScJUN 27, 2023Clinical & Molecular DX
Tuberculosis is still a major health problem in much of the world. It was the primary cause of death from an infectious ...Written By: Carmen LeitchJUN 21, 2023Genetics & Genomics
The Y chromosome is the smallest chromosome, and holds the least amount of genes, but scientists are still learning abou ...Written By: Carmen LeitchJUN 15, 2023Clinical & Molecular DX
When women have denser breasts than average, they may undergo mammograms to screen for breast cancer and be given a clea ...Written By: Carmen LeitchJUN 02, 2023Clinical & Molecular DX
Clinicians and researchers agree that it's best to treat cancer as soon as possible, which means an early diagnosis can ...Written By: Carmen LeitchAPR 27, 2023Clinical & Molecular DX
Prostate cancer impacts men from all ethnic and racial groups, and has particularly high mortality rates compared to oth ...Written By: Carmen LeitchJAN 12, 2023Cancer
Hematopoiesis, a biological process resulting in the formation of new blood cells, occurs throughout our lifetime. ...Written By: Katie KokolusJAN 09, 2023Cancer
Point-of-care diagnoses occur when a doctor can quickly diagnose a patient during an examination without sending biologi ...Written By: Katie KokolusNOV 28, 2022Clinical & Molecular DX
MicroRNAs are small (between just 21 and 23 nucleotides), non-coding RNA molecules. They are involved in the post-transc ...Written By: Zoe MichaudSEP 15, 2022Cancer
Early-onset cancers, typically defined as those diagnosed in people aged approximately 20 - 50, have continually increas ...Written By: Katie KokolusSEP 12, 2022Cancer
Early detection of cancer benefits patients with almost all cancer types. Late-stage tumors remain more difficult ...Written By: Katie KokolusJUN 27, 2022Genetics & Genomics
Breast cancer is the second most common cancer among women in the United States. For some alarming statistics, about 1 i ...Written By: Laurence Tognetti, MScAPR 28, 2022Cancer
It is estimated that over 250.000 men in the United States will receive prostate cancer diagnoses in 2022, acc ...Written By: Katie KokolusFEB 03, 2022Clinical & Molecular DX
Brain tumors are associated with low survival rates for a number of reasons. For one, malignant brain tumors o ...Written By: Tara FernandesDEC 06, 2021Cell & Molecular Biology
To meet the demands of cutting-edge biomedical research, NanoString have launched a spatial transcriptomics platform cal ...NOV 15, 2021Cancer
“Cancer” isn’t a word anyone wants to hear from their doctor. However, many dog owners may not conside ...Written By: Katie KokolusOCT 14, 2021Clinical & Molecular DX
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther ...Written By: Tara Fernandes
FEB 22, 2024
Clinical & Molecular DX
A new tool has been developed to detect skin cancer; it utilizes a biosensor that can identify small changes in the char
...
Written By:
Carmen Leitch
JAN 04, 2024
Clinical & Molecular DX
After leukemia, tumors of the central nervous system (CNS) are second most common cancer in children, and the primary ca
...
Written By:
Carmen Leitch
DEC 13, 2023
Genetics & Genomics
Human immunity is an incredibly complex system that have to be very carefully regulated by the body. We need our immune
...
Written By:
Carmen Leitch
NOV 10, 2023
Clinical & Molecular DX
Globally, bladder cancer is the ninth most commonly diagnosed cancer and is the 13th leading cause of cancer-related dea
...
Written By:
Carmen Leitch
OCT 24, 2023
Technology
A team of researchers at the University Medical Center Utrecht and the Princess Máxima Center for pediatric oncol
...
Written By:
Ryan Vingum
OCT 11, 2023
Clinical & Molecular DX
Tumors in the central nervous system are particularly deadly. During surgery to remove a brain tumor, surgeons usually h
...
Written By:
Carmen Leitch
SEP 29, 2023
Clinical & Molecular DX
The brain is a crucial, sensitive organ that is well-protected by the skull and blood brain barrier, which prevents many
...
Written By:
Carmen Leitch
AUG 17, 2023
Technology
A recent study published in Nature Machine Intelligence examines a novel deep-learning method known as BigMHC, which can
...
Written By:
Laurence Tognetti, MSc
JUN 27, 2023
Clinical & Molecular DX
Tuberculosis is still a major health problem in much of the world. It was the primary cause of death from an infectious
...
Written By:
Carmen Leitch
JUN 21, 2023
Genetics & Genomics
The Y chromosome is the smallest chromosome, and holds the least amount of genes, but scientists are still learning abou
...
Written By:
Carmen Leitch
JUN 15, 2023
Clinical & Molecular DX
When women have denser breasts than average, they may undergo mammograms to screen for breast cancer and be given a clea
...
Written By:
Carmen Leitch
JUN 02, 2023
Clinical & Molecular DX
Clinicians and researchers agree that it's best to treat cancer as soon as possible, which means an early diagnosis can
...
Written By:
Carmen Leitch
APR 27, 2023
Clinical & Molecular DX
Prostate cancer impacts men from all ethnic and racial groups, and has particularly high mortality rates compared to oth
...
Written By:
Carmen Leitch
JAN 12, 2023
Cancer
Hematopoiesis, a biological process resulting in the formation of new blood cells, occurs throughout our lifetime.
...
Written By:
Katie Kokolus
JAN 09, 2023
Cancer
Point-of-care diagnoses occur when a doctor can quickly diagnose a patient during an examination without sending biologi
...
Written By:
Katie Kokolus
NOV 28, 2022
Clinical & Molecular DX
MicroRNAs are small (between just 21 and 23 nucleotides), non-coding RNA molecules. They are involved in the post-transc
...
Written By:
Zoe Michaud
SEP 15, 2022
Cancer
Early-onset cancers, typically defined as those diagnosed in people aged approximately 20 - 50, have continually increas
...
Written By:
Katie Kokolus
SEP 12, 2022
Cancer
Early detection of cancer benefits patients with almost all cancer types. Late-stage tumors remain more difficult
...
Written By:
Katie Kokolus
JUN 27, 2022
Genetics & Genomics
Breast cancer is the second most common cancer among women in the United States. For some alarming statistics, about 1 i
...
Written By:
Laurence Tognetti, MSc
APR 28, 2022
Cancer
It is estimated that over 250.000 men in the United States will receive prostate cancer diagnoses in 2022, acc
...
Written By:
Katie Kokolus
FEB 03, 2022
Clinical & Molecular DX
Brain tumors are associated with low survival rates for a number of reasons. For one, malignant brain tumors o
...
Written By:
Tara Fernandes
DEC 06, 2021
Cell & Molecular Biology
To meet the demands of cutting-edge biomedical research, NanoString have launched a spatial transcriptomics platform cal
...
NOV 15, 2021
Cancer
“Cancer” isn’t a word anyone wants to hear from their doctor. However, many dog owners may not conside
...
Written By:
Katie Kokolus
OCT 14, 2021
Clinical & Molecular DX
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther
...
Written By:
Tara Fernandes